Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticals

touchEXPERT OPINIONS for touchENDOCRINOLOGY

Leading experts share their insights on the role and use of radiopharmaceuticals in adult patients with solid tumours (with a focus on NETs and prostate cancer) and provide guidance for daily clinical practice to support their integration.

The experts:

Part 1 (00:00)

• Dr Stephen Graves, University of Iowa, Iowa City, IA, USA
• Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA 

Part 2 (20:20)

• Prof. Jorge Garcia, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA
• Dr Jason Starr, Mayo Clinic, Jacksonville, FL, USA
• Dr Erik Mittra, Oregon Health and Science University, Portland, OR, USA 

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A and is jointly provided by USF Health and touchIME. 

For further information visit: https://touchendocrinologyime.org/radiopharmaceuticals-adult-oncology-primer/